These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9224861)

  • 1. The effect of fixation condition manipulations on antisaccade performance in schizophrenia: studies of diagnostic specificity.
    McDowell JE; Clementz BA
    Exp Brain Res; 1997 Jun; 115(2):333-44. PubMed ID: 9224861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saccadic disinhibition in patients with acute and remitted schizophrenia and their first-degree biological relatives.
    Curtis CE; Calkins ME; Grove WM; Feil KJ; Iacono WG
    Am J Psychiatry; 2001 Jan; 158(1):100-6. PubMed ID: 11136640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisaccade performance is related to genetic loading for schizophrenia.
    Petrovsky N; Weiss-Motz F; Schulze-Rauschenbach S; Lemke M; Hornung P; Ruhrmann S; Klosterkötter J; Maier W; Ettinger U; Wagner M
    J Psychiatr Res; 2009 Jan; 43(3):291-7. PubMed ID: 18585739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between antisaccade task and working memory task performance in schizophrenia and bipolar disorder.
    Gooding DC; Tallent KA
    J Nerv Ment Dis; 2001 Jan; 189(1):8-16. PubMed ID: 11206670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relation between antisaccade errors, fixation stability and prosaccade errors in schizophrenia.
    Barton JJ; Pandita M; Thakkar K; Goff DC; Manoach DS
    Exp Brain Res; 2008 Mar; 186(2):273-82. PubMed ID: 18057921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Saccadic disinhibition in schizophrenia patients and their first-degree biological relatives. A parametric study of the effects of increasing inhibitory load.
    Curtis CE; Calkins ME; Iacono WG
    Exp Brain Res; 2001 Mar; 137(2):228-36. PubMed ID: 11315552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal stability of saccadic task performance in schizophrenia and bipolar patients.
    Gooding DC; Mohapatra L; Shea HB
    Psychol Med; 2004 Jul; 34(5):921-32. PubMed ID: 15500312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisaccade performance is abnormal in schizophrenia patients but not in their biological relatives.
    Brownstein J; Krastoshevsky O; McCollum C; Kundamal S; Matthysse S; Holzman PS; Mendell NR; Levy DL
    Schizophr Res; 2003 Sep; 63(1-2):13-25. PubMed ID: 12892854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revisiting the suitability of antisaccade performance as an endophenotype in schizophrenia.
    Mazhari S; Price G; Dragović M; Waters FA; Clissa P; Jablensky A
    Brain Cogn; 2011 Nov; 77(2):223-30. PubMed ID: 21924537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced attentional engagement contributes to deficits in prefrontal inhibitory control in schizophrenia.
    Reilly JL; Harris MS; Khine TT; Keshavan MS; Sweeney JA
    Biol Psychiatry; 2008 Apr; 63(8):776-83. PubMed ID: 18191110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated antisaccade error rate as an intermediate phenotype for psychosis across diagnostic categories.
    Reilly JL; Frankovich K; Hill S; Gershon ES; Keefe RS; Keshavan MS; Pearlson GD; Tamminga CA; Sweeney JA
    Schizophr Bull; 2014 Sep; 40(5):1011-21. PubMed ID: 24080895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A goal activation approach to the study of executive function: an application to antisaccade tasks.
    Nieuwenhuis S; Broerse A; Nielen MM; de Jong R
    Brain Cogn; 2004 Nov; 56(2):198-214. PubMed ID: 15518936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring liability for schizophrenia using optimized antisaccade stimulus parameters.
    McDowell JE; Myles-Worsley M; Coon H; Byerley W; Clementz BA
    Psychophysiology; 1999 Jan; 36(1):138-41. PubMed ID: 10098389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saccadic and attentional abnormalities in patients with schizophrenia.
    Maruff P; Danckert J; Pantelis C; Currie J
    Psychol Med; 1998 Sep; 28(5):1091-100. PubMed ID: 9794016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the development of voluntary and reflexive components in human saccade generation.
    Fischer B; Biscaldi M; Gezeck S
    Brain Res; 1997 Apr; 754(1-2):285-97. PubMed ID: 9134986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oculomotor performance in obsessive-compulsive disorder.
    Tien AY; Pearlson GD; Machlin SR; Bylsma FW; Hoehn-Saric R
    Am J Psychiatry; 1992 May; 149(5):641-6. PubMed ID: 1575255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisaccade performance in monozygotic twins discordant for schizophrenia: the Maudsley twin study.
    Ettinger U; Picchioni M; Hall MH; Schulze K; Toulopoulou T; Landau S; Crawford TJ; Murray RM
    Am J Psychiatry; 2006 Mar; 163(3):543-5. PubMed ID: 16513882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shared and distinct oculomotor function deficits in schizophrenia and obsessive compulsive disorder.
    Damilou A; Apostolakis S; Thrapsanioti E; Theleritis C; Smyrnis N
    Psychophysiology; 2016 Jun; 53(6):796-805. PubMed ID: 26914941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saccadic eye movements in different dimensions of schizophrenia and in clinical high-risk state for psychosis.
    Obyedkov I; Skuhareuskaya M; Skugarevsky O; Obyedkov V; Buslauski P; Skuhareuskaya T; Waszkiewicz N
    BMC Psychiatry; 2019 Apr; 19(1):110. PubMed ID: 30961571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisaccade performance in patients with schizophrenia and affective disorder.
    Katsanis J; Kortenkamp S; Iacono WG; Grove WM
    J Abnorm Psychol; 1997 Aug; 106(3):468-72. PubMed ID: 9241948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.